Kalmouni M, Oh Y, Alata W, Magzoub M
Pharmaceutics. 2024; 16(11).
PMID: 39598566
PMC: 11597747.
DOI: 10.3390/pharmaceutics16111443.
Costa A
Brain Sci. 2024; 14(11).
PMID: 39595846
PMC: 11591668.
DOI: 10.3390/brainsci14111084.
Menendez-Gonzalez M
Int J Mol Sci. 2024; 25(19).
PMID: 39408961
PMC: 11476806.
DOI: 10.3390/ijms251910632.
Iwata N, Tsubuki S, Sekiguchi M, Watanabe-Iwata K, Matsuba Y, Kamano N
Life Sci Alliance. 2024; 7(12).
PMID: 39348937
PMC: 11443169.
DOI: 10.26508/lsa.202402650.
Paterno G, Moore B, Bell B, Gorion K, Ran Y, Prokop S
Antibodies (Basel). 2024; 13(3).
PMID: 39189239
PMC: 11348109.
DOI: 10.3390/antib13030068.
Brain proteomic analysis implicates actin filament processes and injury response in resilience to Alzheimer's disease.
Huang Z, Merrihew G, Larson E, Park J, Plubell D, Fox E
Nat Commun. 2023; 14(1):2747.
PMID: 37173305
PMC: 10182086.
DOI: 10.1038/s41467-023-38376-x.
Controlling Amyloid Beta Peptide Aggregation and Toxicity by Protease-Stable Ligands.
Mallesh R, Khan J, Gharai P, Gupta V, Roy R, Ghosh S
ACS Bio Med Chem Au. 2023; 3(2):158-173.
PMID: 37101809
PMC: 10125337.
DOI: 10.1021/acsbiomedchemau.2c00067.
PICALM and Alzheimer's Disease: An Update and Perspectives.
Ando K, Nagaraj S, Kucukali F, de Fisenne M, Kosa A, Doeraene E
Cells. 2022; 11(24).
PMID: 36552756
PMC: 9776874.
DOI: 10.3390/cells11243994.
Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43.
Tarutani A, Adachi T, Akatsu H, Hashizume Y, Hasegawa K, Saito Y
Acta Neuropathol. 2022; 143(6):613-640.
PMID: 35513543
PMC: 9107452.
DOI: 10.1007/s00401-022-02426-3.
Alzheimer's disease - the journey of a healthy brain into organ failure.
Golde T
Mol Neurodegener. 2022; 17(1):18.
PMID: 35248124
PMC: 8898417.
DOI: 10.1186/s13024-022-00523-1.
An ultra-sensitive immunoassay detects and quantifies soluble Aβ oligomers in human plasma.
Liu L, Kwak H, Lawton T, Jin S, Meunier A, Dang Y
Alzheimers Dement. 2021; 18(6):1186-1202.
PMID: 34550630
PMC: 8938295.
DOI: 10.1002/alz.12457.
Significance of mitochondrial activity in neurogenesis and neurodegenerative diseases.
Ozgen S, Krigman J, Zhang R, Sun N
Neural Regen Res. 2021; 17(4):741-747.
PMID: 34472459
PMC: 8530128.
DOI: 10.4103/1673-5374.322429.
Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery.
Bai B, Vanderwall D, Li Y, Wang X, Poudel S, Wang H
Mol Neurodegener. 2021; 16(1):55.
PMID: 34384464
PMC: 8359598.
DOI: 10.1186/s13024-021-00474-z.
Wild-type sTREM2 blocks Aβ aggregation and neurotoxicity, but the Alzheimer's R47H mutant increases Aβ aggregation.
Vilalta A, Zhou Y, Sevalle J, Griffin J, Satoh K, Allendorf D
J Biol Chem. 2021; 296:100631.
PMID: 33823153
PMC: 8113883.
DOI: 10.1016/j.jbc.2021.100631.
Tau Pathology and Adult Hippocampal Neurogenesis: What Tau Mouse Models Tell us?.
Houben S, Homa M, Yilmaz Z, Leroy K, Brion J, Ando K
Front Neurol. 2021; 12:610330.
PMID: 33643196
PMC: 7902892.
DOI: 10.3389/fneur.2021.610330.
Aβ-Induced Damage Memory in hCMEC/D3 Cells Mediated by Sirtuin-1.
Liu H, Zhang Y, Zhang H, Xu S, Zhao H, Liu X
Int J Mol Sci. 2020; 21(21).
PMID: 33153131
PMC: 7662699.
DOI: 10.3390/ijms21218226.
Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.
Solis Jr E, Hascup K, Hascup E
J Alzheimers Dis. 2020; 76(4):1179-1198.
PMID: 32597813
PMC: 7483596.
DOI: 10.3233/JAD-200473.
Tau and Axonal Transport Misregulation in Tauopathies.
Combs B, Mueller R, Morfini G, Brady S, Kanaan N
Adv Exp Med Biol. 2020; 1184:81-95.
PMID: 32096030
PMC: 7099581.
DOI: 10.1007/978-981-32-9358-8_7.
Zebrafish as an Emerging Model for Bioassay-Guided Natural Product Drug Discovery for Neurological Disorders.
Pitchai A, Rajaretinam R, Freeman J
Medicines (Basel). 2019; 6(2).
PMID: 31151179
PMC: 6631710.
DOI: 10.3390/medicines6020061.
Amyloid Load: A More Sensitive Biomarker for Amyloid Imaging.
Whittington A, Gunn R
J Nucl Med. 2018; 60(4):536-540.
PMID: 30190305
PMC: 6448463.
DOI: 10.2967/jnumed.118.210518.